Chinese cell therapy startup iRegene Therapeutics has raised CNY210 million (USD31 million) in a C1 financing round to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results